Interestingly, although the use of both MCP-counter and TIMER identified positive correlations between FTL and FTH1 expressions and CD4+ or CD8+ T cells in fewer than 50% of the cancer types examined, analysis of TIMINER identified a much higher rate of association between FTL and FTH1 expressions and tumor-infiltrating immune cell subsets. The gene discussed is FTL; the disease is neoplasm.